What Is a Better Investment Right Now: Olaplex or L'Oreal?

These two companies have been locked in litigation over patent infringement, but which is the better investment now: Olaplex or L'Oreal?
Oct. 18, 2021
Unlock Free Stock Insights + 50% Off Discount Code!
Join thousands of savvy investors and get:
  • Weekly Stock Picks: Handpicked from 60,000 global options.
  • Ten Must-Have Stocks: Essential picks to hold until 2034.
  • Exclusive Stock Library: In-depth analysis of 60 top stocks.
  • Proven Success: 10-year track record of outperforming the market.
Sign up to our mailing list now and enjoy a 50% discount on premium services!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy and Terms of Use.

Olaplex (NASDAQ: OLPX) went public two weeks ago on the strength of its products designed to repair damaged, over-colored hair. L'Oreal (OTCMKTS: LRLCY) has been around for over 100 years and was recently the defendant in a patent infringement lawsuit by the younger company; it lost and filed for an appeal, which it won and the judgment was reversed. Amidst all this drama, which stock is the better investment right now: Olaplex or L'Oreal?

Olaplex: the bulls and the bears

Olaplex has a powerful moat in its scientifically-backed products; in fact, it holds over 100 patents in the hair care field. Initially only selling to salons and professionals, the company now has a retail channel for direct-to-consumer business. People are taking notice and according to the company's latest quarterly report (Q2 2021), net sales are up over 175% and net income surged over 2,300% year-over-year (YoY). 

The company's products, which target the hair follicle bond, have strong consumer loyalty, but more importantly, they also have a strong professional following to help drive business. Additionally, Olaplex has a strong social media presence, where it secured many more followers on TikTok and Instagram than competitors. And yes, the company is profitable. 

However, Olaplex is young and doesn't have as much money as competitors and that leaves it open to attacks by Goliaths like L'Oreal. In fact, L'Oreal got its hands on Olaplex's trade secrets by tempting the company with a buy-out and during this transaction peeked inside the cookie jar. Competitors like this, with deep pockets, and more business experience, are a threat.

L'Oreal: The bulls and the bears

In H1 2021, L'Oreal reported a 16.2% increase in sales, an 18.4% rise in gross profit, and a 26.8% growth in operating profit, not to mention double-digit like-for-like growth in three out of its four divisions, year-to-date (YTD). The company pays a dividend of EUR4 ($5.48) and its stock price has climbed over 20%, YTD. L'Oreal is the world's largest cosmetics company and has brands like Maybelline, Lancome, and Urban Decay in its portfolio of nearly 40 hugely popular lines. 

Being such a titan in the field has its downsides particularly in the ethics category. The company gets poor marks for animal testing, having operations in countries with oppressive regimes, and neglecting to eliminate environmentally toxic ingredients from their products, according to Ethical Consumer.

So, which stock is a better buy right now?

Regardless of our policy not to suggest companies without at least two earnings reports, L'Oreal is still clearly the long-term play here. This formidable organization has a wide array of popular brands and will likely continue to acquire more (Olaplex was a candidate at one point). Further, I reckon it won't be long before L'Oreal develops its own line of follicle-bond treatment products. It might seem expensive, edging in at $400, but this is a company that has historically outperformed the market in growth and will likely continue to do so.


Unlock Free Stock Insights +50% Off Discount Code!
Join thousands of savvy investors and get:
  • Weekly Stock Picks: Handpicked from 60,000 global options.
  • Ten Must-Have Stocks: Essential picks to hold until 2034.
  • Exclusive Stock Library: In-depth analysis of 60 top stocks.
  • Proven Success: 10-year track record of outperforming the market.
Sign up to our mailing list now and enjoy a 50% discount on premium services!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy and Terms of Use.

The Home of Successful Investing.

© 2024 MyWallSt Ltd. All rights reserved.


Services

Content

Social

Company

Support

Resources


This website is operated by MyWallSt Ltd (“MyWallSt”). MyWallSt is a publisher and a technology platform, not a registered broker-dealer or registered investment adviser, and does not provide investment advice. All information provided by MyWallSt Limited is of a general nature for information and education purposes, and you should not construe any such information as investment advice. MyWallSt Limited does not take your specific needs, investment objectives or financial situation into consideration, and any investments mentioned may not be suitable for you. You should always carry out your own independent verification of facts and data before making any investment decisions, as we cannot guarantee the accuracy or completeness of any information we publish and any opinions that we publish may be wrong and may change at any time without notice. If you are unsure of any investment decision you should seek a professional financial advisor. MyWallSt Limited is not a registered investment adviser and we do not provide regulated investment advice or recommendations. MyWallSt Limited is not regulated by the Central Bank of Ireland. MyWallSt Limited may provide hyperlinks to web sites operated by third parties. Your use of third party web sites and content, including without limitation, your use of any information, data, advertising, products, or other materials on or available through such web sites, is at your own risk and is subject to the third parties' terms of use.